Mr. Speaker, I rise today to announce that I am today introducing the Ovarian Cancer and Research Amendments of 2001. I am proud to be joined by 56 original co-sponsors and would like to invite the rest of my colleagues to join me in support of the bill.
Ovarian cancer is the most lethal cancer of the female reproductive system, primarily because it is so difficult to detect in its early stages. While survival rates are quite high if the disease is found before it spread beyond the ovaries, the five-year survival rate drops to 28% for women who are diagnosed and treated in the later stages of the disease. Only 25% of ovarian cancer cases are caught in the earliest stages.
The Ovarian Cancer and Research Amendments of 2001 have three components. First, it authorizes $150 million for ovarian cancer research: one- half to be spent on basic cancer research and one-half on clinical trials and treatment. The bill requires that priority be given to developing a test for the early detection of ovarian cancer; research to identify precursor lesions and to determine the manner in which benign conditions progress to malignant status; and research to determine the relationship between ovarian cancer and endometriosis. Moreover, the bill requires that appropriate counseling be provided to women participating in clinical trials. Second, the bill provides for a comprehensive education program to provide information to patients and the public on screening procedures, the genetic basis to ovarian cancer, factors that increase the risk of getting ovarian cancer; and any new treatments for ovarian cancer. Finally, it requires that the National Cancer Advisory Board include at least one individual who is at high risk of developing ovarian cancer. I hope all my colleagues will join me in supporting this worthy cause and help to give women a fighting chance against ovarian cancer.
The Ovarian Cancer Research And Information Amendments Of 2001
Msia/Kul 2 Post docs & 3 Research Associates in Cancer research
The Cancer Research Initiatives Foundation (CARIF) is the first independent Malaysian fundamental cancer research organization. We seek an understanding of the genetic basis of cancers in Malaysia through molecular analysis. The specific projects are described below:
1) Identification & characterization of genetic changes in oral, nasopharyngeal & liver cancer using whole genome approaches such as SAGE and microarrays
2) Characterization of sequence variations in the Asian population that are linked to an increased disposition to breast cancer
3) Novel cancer therapies derived from local flora: Isolation and characterization of novel light-activated compounds from Malaysian plants
CARIF is now offering the abovementioned positions for scientists who are enthusiastic to join our team.
I. Post doctoral research scientist (2 positions) You will have a PhD in genetics or related field, preferably with post-doctoral experience. You will be part of project 1 or 2 described above and report to the CEO and the Board of Trustees.
II. Research Associate (3 positions) You will assist the Project Leader in project 1 or project 2 above. You will have an MSc in molecular biology, genetics or related biology field.
REVEALING MY SECRET RESEARCH
It is almost a year since I have come to this ng. You heard many times how I verify all I hear, read. Not long ago, there was a research done in Europe which said that the most single reason for cancer in human is lack of respect we experience in our lives. Looking at the people whom I knew, looking into my experiences it stroked me as something very probable.
Almost at the same time coincidentally I started to look into Freemasonry. When I started reading this ng there seemed to be lots of disrespect toward ‘cowans’ non masons and others. Not immediately, but after a while I decided on an experiment. This ng was a perfect environment for it. Will my cancer return or not if I allow myself to feel that disrespect from you?
While my heart went to others I willingly submitted myself. I had times of scare, of pain, the desire to leave sooner but I was convinced there must be more time, at least a year (on average 18 months) of that treatment to see the results. Now at the request and begging from my family and friends I will leave you. They say it is enough!!! I we all agree with that. I will allow myself to be observed here in Canada for some time before I go to Europe where loving people beg me to come back.
Meanwhile, I have good news. I bought myself a bright new home and soon will start entirely new life in a new place. I will not read this ng anymore and please do not comment. I know it now that was the most ‘kooky’ idea I have ever had.
Marijuana May Stall Brain Tumor Growth
Researchers say the cannabinoids found in marijuana may aid in brain tumor treatment by targeting the genes needed for the tumors to sprout blood vessels and grow. Their study showed that cannabinoids inhibited genes needed for the production of vascular growth factor (VEGF) in laboratory mice with glioma brain tumors and two patients with late-stage glioblastoma multiforme, a form of brain cancer.
VEGF is a protein that stimulates blood vessels to grow. Tumors need an abundant blood supply because they generally grow rapidly. So when VEGF is blocked, tumors starve from lack of blood supply and nutrients. Blocking of VEGF constitutes one of the most promising tumor-fighting approaches currently available, says researcher Manuel Guzman, professor of biochemistry and molecular biology, at the Complutense University in Madrid, Spain, in a news release.
Guzman says the findings suggest VEGF may be a new target for cannabinoid-based treatments. Previous studies have shown that cannabinoids could inhibit the growth of tumor-associated blood vessels in mice, but until now little was known about how they worked. The results of the study appear in the Aug. 15 issue of the journal Cancer Research. Cannabinoids May Help Starve Tumors
In the study, researchers looked at the effects of cannabinoid treatment on gliobastoma multiforme, a form of brain cancer that affects about 7,000 Americans each year. It’s considered one of the deadliest forms of cancer and usually results in death within one to two years after diagnosis. Treatment typically involves surgery, followed by radiation and/or chemotherapy. But despite these efforts to destroy the tumor, this type of brain tumor often survives and starts growing again, which is why researchers are looking for novel ways to attack it.
In order to grow, all tumors require a network of blood vessels to feed them, and they create this network through a process known as angiogenesis. VEGF is critical to this process. In the first part of the study, researchers induced brain cancer in mice and then treated them with cannabinoids. They then analyzed the genes associated with the growth of blood vessels in the tumor and found that cannabinoids inhibited several of the genes related to VEGF. In the second part of the study, researchers injected cannabinoids into tumor samples taken from two human glioblastoma patients.
“In both patients, VEGF levels in tumor extracts were lower after cannabinoid inoculation,” says Guzman. Researchers say more study is needed but the results suggest that cannabinoid-based therapies may offer a new alternative for treatment of these otherwise untreatable brain tumors.
American Cancer Society a Danger to Science?
The credibility of the peer review process has come under vehement attack. Scientists who receive no-strings-attached financial support for their research from demonized industries – tobacco, pharmaceuticals, and food, among others – are no longer deemed trustworthy.
Apparently, the rigors of the peer review process – even in the world’s best science and medical journals – in addition to full disclosure requirements, isn’t enough to prevent “biased” studies from being published. Activists – displeased with results that undermine their agenda – cry bias, and prestigious science and health organizations cave, preferring to appease the advocates, rather than allow the scientific method to weed out bad science.
One of the country’s most distinguished cancer organizations has succumbed to the prohibitionist faction of the anti-tobacco movement’s demagogic rhetoric. Accepting and adopting these crusaders’ guilt-by-association arguments at face value, rather than identifying flaws in the research results they oppose.
Earlier this year, the American Cancer Society (ACS) passed a resolution barring scientists who receive financial support from the tobacco industry from receiving ACS grants. Responding to news of the resolution, Dr. Elizabeth Whelan warned ACS (see letter below) against their injurious adoption of such a litmus test. Using funding as a basis for rejection is detrimental to the process of providing unbiased, peer-reviewed health information.
Such policies have unseen costs and unintended consequences. They may produce biased research by cherry-picking authors and results and confusing public debate – mirroring the tobacco industry’s stratagem. Further, they set a dangerous precedent by giving opponents of sound science a new weapon. If the science is faulty, we should use science itself, not ad hominem or innuendo, to detect the problems.
ACS’s response to our criticsm? Six months later, we’re still waiting. Regardless of whether we ever receive a reply, we hope ACS got the message. Putting science ahead of ideology is best for cancer patients as well as the general public, who rely on good science – that which is able to survive the rigors of peer review – not simply good intentions.
USA Today: “Plant foods to the rescue”
Scientists who study nutrition paint a very different picture.
A growing body of research shows that, once inside the body, fruits and vegetables spring into the role of superheroes, fighting cancer and other diseases in at least eight simultaneous ways. And, like the Superfriends, they seem to work better as a team. Some phytochemicals, or plant chemicals, knock out carcinogens and fight inflammation. Some regulate how quickly cells reproduce and spur old, damaged cells to self-destruct. Other plant chemicals perform “routine maintenance” on DNA, says Jeff Prince, vice president for education at the Washington-based American Institute for Cancer Research.
Doctors caution that recent research indicates that fruits and vegetables may not provide as much protection against cancer as once believed. In the past five years, studies have shown that weight control may be more crucial, says Walt Willett, chairman of the nutrition department at the Harvard School of Public Health.
Yet most experts agree that the body needs a variety of these phytochemicals – there are more than 25,000 of them – to stay in top form. That’s why so many nutritionists no longer stress individual “power foods,” Prince says, but instead promote a “plant-based” diet of fruits, vegetables, whole grains, beans and nuts. Preliminary research indicates these foods bring out the best in each other and magnify their protective effects.
At the cancer institute’s annual scientific conference in July, researchers from the University of Illinois-Urbana described their research feeding tomatoes and broccoli to lab rats that had prostate cancer. The tumors of rats that were fed both vegetables shrank far more than those of animals who ate either food alone. Researchers stressed, though, that people do not necessarily react the same way as animals and that many larger studies need to be done to confirm these results.
“The take-home message is not that experts recommend tomatoes and broccoli,” Prince said at the conference. “We’re not going to find a single source that fights disease. What’s important is the interaction of thousands of plant chemicals.” Humans evolved to depend on a rich diet of 800 plant foods, says David Heber, director of the University of California-Los Angeles Center for Human Nutrition. Today, he says, most people eat three, and those are often french fries, ketchup and iceberg lettuce.
Yet some potentially potent plant foods, experts say, are exotic varieties that Americans rarely sample: herbs such as ginseng; spices such as turmeric, used in Indian cooking; and Reishi and Maitake mushrooms from Japan. Heber suggests that people select their five to nine recommended daily servings of fruits and vegetables from seven color groups, such as purple grapes or yellow squash, whose colors are produced by disease-fighting chemicals called carotenoids.
Scientists have identified only a handful of the thousands of potentially beneficial plant chemicals, says Daniel Nixon, author of The Prostate Health Program and president of the Institute for Cancer Prevention in New York. People who would rather pop dietary supplements instead of eating the real thing may miss out on proven health promoters such as fiber, as well as compounds that scientists have yet to discover, Nixon says. Last week, the American Heart Association published an advisory finding that antioxidant supplements do not prevent heart disease. In some studies, supplements with beta carotene – the chemical that colors carrots orange – increased the risk of cancer.
Plants vs. disease
Plant foods, however, may help prevent a number of diseases, says Rachel Brandeis of the American Dietetic Association. Antioxidants found in vegetables neutralize dangerous molecules called “free radicals,” which are produced by smoking and radiation, as well as everyday activities of the body. Left to themselves, free radicals attack healthy cells and may lead to plaques in the arteries and even Alzheimer’s. They also can damage DNA in ways that lead to cancer. As plants evolved, they developed antioxidants to fight free radicals, Heber says. Humans grew to depend on fruits, vegetables and nuts to provide these vital defenses. That may explain why, without a rich plant diet, people are more vulnerable to disease. Diets rich in plant compounds, on the other hand, may prevent a variety of ailments.
At a meeting of the Alzheimer’s Association last month, for example, researchers presented the results of a six-year study of 3,000 senior citizens. In the study, people who consumed lots of vitamin C and carotenoids, both through food and supplements, scored higher on reasoning tests. Carotenoids are found in squash, strawberries and other fruits. According to another study presented at the meeting, vegetables such as spinach and broccoli – which contain vitamin C and carotenoids, as well as the vitamin folic acid – were found to slow cognitive decline.
Other things that appear to lower the risk of Alzheimer’s include vitamin E, found in wheat germ, and fatty fish, such as salmon and mackerel, which are rich in omega-3 fatty acids, according to the Alzheimer’s Association. Scientists say they still have many questions about antioxidants: Can they fight cancer at any stage of the disease or at any age? Or do people benefit only if they consume these foods from infancy? Under which circumstances might antioxidants promote disease, rather than healing?
Scientists have identified at least a handful of the ways that plant foods appear to fight disease, says Cheryl Rock, a professor of nutrition at the University of California-San Diego Cancer Center. * By mopping up free radicals, antioxidants such as the beta carotene in sweet potatoes or the vitamin E in almonds prevent cell damage. Another class of chemicals called flavonoids have been shown to activate the body’s natural DNA repair system.
* Fruits and vegetables often are high in potassium, which can help control blood pressure.
* Antioxidants may interrupt a process leading to inflammation, which appears to play a role in cardiovascular disease and cancer. Vitamin B6, found in bananas, and folic acid, found in broccoli and leafy greens, both lower levels of homocysteine, which has been linked to hardening of the arteries, heart attacks, strokes and dementia.
* Chemicals such as beta carotene also help regulate the natural cycle of cell birth and death, telling cells when to divide, differentiate into new types or recycle themselves. Keeping this process under tight control can prevent cancer, Rock says.
* Phytochemicals in foods such as Brussels sprouts, red cabbage and kale may help prevent cancer by activating enzymes that break down carcinogens.
Antioxidants vs. angiogenesis
* Emerging research suggests that antioxidants may shut down a process called angiogenesis, by which tumors recruit blood supplies that help them grow and spread, says William Li, president of the Angiogenesis Foundation. Scientists are investigating links between angiogenesis and compounds found in foods such as licorice, blueberries and garlic, Li says.
Researchers who studied tumors in mice were able to cut back the number of new blood vessels by 70% simply by replacing their water with green tea, Li says. Scientists have not proved this link in humans.
* Plant foods such as whole-grain cereals and oats are loaded with fiber. In a study of 40,000 male health professionals, high-fiber diets reduced the risk of coronary heart disease by 40%. Diets filled with cereal fiber also may help prevent diabetes and a painful intestinal inflammation called diverticular disease. “Mother Nature is cleverer than all of us and has laced many of our favorite foods with things that can be helpful,” Li says. “Ancient cultures have long recognized that your diet can be healing, and
scientists are only now beginning to understand why.” Digest the benefits of this basket of foods
Many nutritionists today stress the importance of healthy dietary patterns – ones filled with vegetables, fruits, whole grains, beans, nuts and lean proteins – combined with regular exercise and weight control. Though no one food is a “magic bullet,” some experts encourage people to include foods such as these in their diets.
Digest the benefits of this basket of foods
Many nutritionists today stress the importance of healthy dietary patterns ones filled with vegetables, fruits, whole grains, beans, nuts and lean proteins – combined with regular exercise and weight control. Though no one food is a “magic bullet,” some experts encourage people to include foods such as these in their diets. Tomatoes The carotenoid lycopene. Eating several servings a week may reduce the risk of prostate cancer up to 35% and also may reduce the risk of heart attack and stroke. To get the most lycopene, cook tomatoes with a little “healthful” fat, such as olive oil.
Whole-grain breads and cereals Fiber and antioxidants. May lower the risk of heart disease by 40%. May also help prevent diabetes. Read labels to make sure that the first ingredient in the bread says whole wheat, not just wheat or “stone-ground wheat.” Salmon, mackeral, sardines Omega-3 fatty acids. Reduces risk of heart disease, diabetes and possibly Alzheimer’s and cancer. Reduces inflammation, which may help prevent or relieve symptoms of arthritis. Contains vitamin D, which builds strong bones and may protect against colon cancer. Cooked, to kill microorganisms and parasites. Broiled, to eliminate contaminants found in freshwater fish. For canned fish, serve with the soft, mashed, calcium-rich bones.
Spinach and other leafy greens Folic acid. This may reduce risk of birth defects, heart attack, Alzheimer’s, depression and inflammation. Folic acid also reduces the risk of fractures. Potassium lowers blood pressure and the danger of strokes. The carotenoids lutein and zeaxanthin may help fight age-related eye disease. Antioxidants called flavones may reduce breast cancer risk. Fresh or lightly steamed to preserve vitamin C; with nuts, olive oil or avocados, whose fat helps to increase absorption of antioxidants.
Blueberries or other berries Antioxidants such as vitamin C. These may reduce risk of heart disease, cancer, mental decline and other diseases of aging. May help prevent urinary-tract infections by inhibiting bacteria. Fresh, raw or lightly cooked. Wash them just before serving to avoid mold and bruising. Canning blueberries removes half of the vitamin C. Sweet potatoes Carotenoids, which may help reduce the risk of Alzheimer’s. Beta carotene also may lower the risk of cancers of the larynx, esophagus and lungs. Baked or boiled.
Male breast cancers ‘more common’
More men are developing breast cancer – but most fail to spot tumours until they are at an advanced stage, a study has warned. University of Texas research found that, while men are far less likely to develop breast tumours than women, the numbers are increasing. Writing in an online edition of the journal Cancer, they warn men seem to be unaware they can develop the cancer.
UK experts said the cancer was rare, but men should be aware of changes. It is important to visit your GP straight away if you notice any change in your body that is not normal Henry Scowcroft, Cancer Research UK The researchers looked at a National Cancer Institute data on cancer incidence and survival in the US from 1973 to 1998. They found that, over the last 20 years, the incidence of male breast cancer had increased from 0.86 to 1.08 per 100,000 men. They then examined 2,524 cases of male breast cancer and 380,856 cases of female breast cancer on the database, diagnosed over that period. The researchers found that compared to female patients, men tended to be significantly older when they were diagnosed – 67 years versus 62 years of age.
They were also more likely to have later stage disease and had more spread of the cancer to their lymph nodes. ‘Easier to spot’ Professor Sharon Giordano, who led the research, said: “Male breast cancer is rare, accounting for less than one per cent of all breast cancer. “But she said: “Men should be alert to the possibility that the disease could affect them.” Professor Giordano added: “It’s perhaps ironic that tumours in men are easier to feel than they are in women, yet the disease is being discovered at a later stage in men than in women.” The researchers say that part of the reason for late diagnosis may be that men assume they are experiencing a benign condition called gynecomastia, or breast tissue growth, that affects about a third of males at some point in their lives.
The condition, which is common in teenage boys, can come and go over a man’s lifetime. Professor Giordano said: “Men may think new growth of breast tissue is just another occurrence of this condition.” The team also found that men often had more larger tumours which had spread further and more aggressive forms of cancer when they were diagnosed.However, survival rates for men and women were no different. The researchers said men were more likely than women to have oestrogen-positive tumours. Professor Giordano: “We are not sure why this is so, but it may indicate some important differences in tumour biology.”In addition, this implies that use of tamoxifen in men may be as beneficial as it is to many women.” She added: “Now that we have a clearer understanding of the biology of breast cancer in men, further research is needed to determine the optimal treatment for men.”
‘Campaigns aimed at women’
Henry Scowcroft, Science Information Officer at Cancer Research UK said: “Breast cancer is very rare among UK men, and when it does occur, it tends to do so between the ages of 60 and 70.”Only about 300 men are diagnosed with the disease each year, compared with about 41,000 new cases in women. Because of this, most breast cancer awareness campaigns are aimed at women. “While Cancer Research UK does not recommend that men, especially young men, examine themselves regularly, it is important to visit your GP straight away if you notice any change in your body that is not
normal.”
US-CA, An Associate Scientist in Cell Biology, Cancer Research
COMPANY
Well-equipped U.S. research headquarters of international drug discovery company. Attractive campus. Excellent resources. High caliber of science. Company is committed to cutting edge research. Provides cutting-edge tools and support. Highly collaborative environment.
DESCRIPTION
Cell biology associate scientist for a cancer research group heavily focused on breast cancer. Apply 3 to 5 years of relevant experience ideally acquired within an industrial biotech environment.
RESPONSIBILITIES
Within a cell biology department, support cancer research genomics program focused on breast cancer. Apply knowledge in cell biology, cell based assays, cell-cell and cell-matrix signaling mechanisms, and antibody experience. Develop, optimize and perform cell-based assays to evaluate novel-gene therapeutic candidates. Validate novel protein drug targets utilizing strategies such as neutralizing antibodies and anti-sense oligonucleotide-based gene knock-outs. Another validation method used will be transfections of wild-type and dominant negative protein.
LOCATION
San Francisco Bay Area.
QUALIFICATIONS
BS or MS in cell biology with 3 to 5 years of pertinent experience, ideally within an industrial biotech setting. Broad knowledge of cell biology. Cell based assay experience (ex: proliferation, apoptosis, migrations and/or invasion assays). Experience working with cancer cell lines. The ability to manipulate a cell is important. Two crucial areas of technical knowledge are: 1.) Mammalian cell transfection and 2.) Delivering antisense oligonucleotides. Ideally we are seeking experience in the culture and transfection of primary and established human cell lines. Strong interpersonal and problem solving skills also important..
DESIRED (Not Mandatory)
Possible growth factor experience. Extracellular matrix interaction. Familiarity with: DNA expression vectors. Antisense olignucleotides. Immuno-cytochemistry and antibody characterization. Molecular biology techniques: such as cDNA cloning, DNA and RNA isolation. Northern and Western blot analysis.
COMPENSATION
Competitive salary and benefits.
Postage Stamp to Raise Money for Cancer Research
LOS ANGELES- the Postal Service unveiled the design of the Breast Cancer Research “Semipostal” Stamp, here, at the Revlon Run and Walk for Women on May 9th. A nationwide issuance of this self-adhesive stamp begins in early August.
As a 40 cent “semipostal,” the Breast Cancer Research stamp will be deemed valid for postage at the prevailing First Class Rate, currently 32 cents, with the extra 8 cents going to fund medical research at the National Institutes of Health (70 percent) and Department of Defense (30 percent).
The background of the vertically formatted stamp design features blue,yellow, orange, and green washes of watercolor. Along the top are the words, “breast cancer” in capital letters. A black ink drawing of a female figure is the main element, while the phrases “fund the fight” and “find a cure” appear in capital letters flowing left to right into a clockwise, circular pattern.
The stamp was designed by Ethel Kessler, a breast cancer survivor, of Bethesda, MD, and illustrated by Whitney Sherman of Baltimore, MD. This is the first time in history that the U.S. Postal Service has issued a “semipostal” stamp. It took an act of Congress after “grass roots” campaigning by several groups led by Dr. Ernie Bodai of Sacramento, CA, to get this unique postage stamp issued.
Among the thousands at the unveiling ceremony, was Mercy Davidchik of Yuba City, CA, who was one of the most active volunteer workers in raising public support and promoting legislation to issue the Breast Cancer Research Stamp. It is hoped that through purchase of these stamps, millions of dollars will be raised for breast cancer research, which is considered the most commonly diagnosed cancer among all women in the U.S.
Breast Cancer Research Semi-postal Stamps
Breast Cancer Research Semi-postal Stamps are subject to special limitations and conditions:
a. Breast Cancer Research Semi-postal Stamps provide a means for customers to make contributions toward breast cancer research. Breast Cancer Research Semi-postal Stamps are offered for sale for a limited time as provided under 39 U.S.C. 414.
b. The price of the Breast Cancer Research Semi-postal Stamp is 40 cents. The postage value of the Breast Cancer Research Semi-postal Stamp is the First-Class Mail Non automation Single-Piece first-ounce letter rate in R100.1.2 that is in effect at the time of purchase. The difference between the purchase price and the First-Class Mail Non automation Single-Piece first-ounce letter rate in effect at the time of purchase constitutes a contribution to breast cancer research, and cannot be used to pay postage. Additional postage must be affixed to pieces weighing in excess of one ounce, pieces subject to the nonstandard surcharge, or pieces for which special services have been elected. The postage value of Breast Cancer Research Semi-postal Stamps is fixed according to the First-Class Mail Non automation Single-Piece first-ounce letter rate in effect at the time of purchase; the postage value of Breast Cancer Research Semi-postal Stamps purchased before any subsequent change in the First-Class Mail Non automation Single-Piece first-ounce letter rate is unaffected by any subsequent change in that rate.
c. Contributions to breast cancer research made through purchase of Breast Cancer Research stamps are not refundable. The postage value of Breast Cancer Research stamps for purposes of exchange or conversion under P014 is determined by the First-Class Mail Non automation Single-
Piece rate in effect at the time of purchase



